Journal of General Virology, Vol 78, 775-783, Copyright © 1997 by Society for General Microbiology

ARTICLES

Paramyxovirus-induced syncytium cell formation is suppressed by a dominant negative fusion regulatory protein-1 (FRP-1)/CD98 mutated construct: an important role of FRP-1 in virus-induced cell fusion

K Okamoto, S Ohgimoto, M Nishio, M Tsurudome, M Kawano, H Komada, M Ito, Y Sakakura and Y Ito
Department of Microbiology, Mie University School of Medicine, Japan.

Syncytium formation and subsequent generalized cell fusion have been reported as potentially important mechanisms of virus-induced cytotoxic effects. We tried to clarify the roles of fusion regulatory factor-1 (FRP-1) in virus-induced cell fusion. Two mutated human FRP-1/CD98 proteins [FRP-1/HN, in which the cytoplasmic domain was replaced with the cytoplasmic domain of human parainfluenza virus type 2 (HPIV-2) haemagglutinin-neuraminidase (HN), and FRP-1/330 (serine), in which a cysteine at amino acid 330 was mutated to serine], when expressed stably in L929 cells, were lacking in cell-fusion-enhancing activity stimulated by anti-FRP-1 antibodies. Anti-FRP-1 antibodies enhanced Newcastle disease virus (NDV)-mediated polykaryocyte formation in parent HeLa cells, while anti-FRP-1 antibodies showed no/low effect on polykaryocyte formation in NDV-infected HeLa cells constitutively expressing FRP-1/HN (HeLa-FRP-1/HN cells), indicating that the FRP-1/HN molecule is capable of acting as a dominant negative inhibitor. Furthermore, when HeLa-FRP-1/HN cells were infected with various rubulaviruses (HPIV-2, mumps virus, simian viruses 5 and 41), virus- induced cell fusion was also suppressed, although virus replication was not inhibited in these cells, showing that FRP-1 molecules are required for virus-induced cell fusion. Therefore, FRP-1 is considered to be related to the pathogenesis of paramyxoviruses.

This article has been cited by other articles:

				M. V. Veettil, S. Sadagopan, N. Sharma-Walia, F.-Z. Wang, H. Raghu, L. Varga, and B. Chandran Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins ({alpha}V{beta}5, {alpha}V{beta}3, and {alpha}3{beta}1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of Infection J. Virol., December 15, 2008; 82(24): 12126 - 12144. [Abstract] [Full Text] [PDF]

				S. Cai, N. Bulus, P. M. Fonseca-Siesser, D. Chen, S. K. Hanks, A. Pozzi, and R. Zent CD98 modulates integrin {beta}1 function in polarized epithelial cells J. Cell Sci., March 1, 2005; 118(5): 889 - 899. [Abstract] [Full Text] [PDF]

				R. C. Rintoul, R. C. Buttery, A. C Mackinnon, W. S. Wong, D. Mosher, C. Haslett, and T. Sethi Cross-Linking CD98 Promotes Integrin-like Signaling and Anchorage-independent Growth Mol. Biol. Cell, August 1, 2002; 13(8): 2841 - 2852. [Abstract] [Full Text] [PDF]

				M. Moll, H.-D. Klenk, and A. Maisner Importance of the Cytoplasmic Tails of the Measles Virus Glycoproteins for Fusogenic Activity and the Generation of Recombinant Measles Viruses J. Virol., June 14, 2002; 76(14): 7174 - 7186. [Abstract] [Full Text] [PDF]

				J. Chillaron, R. Roca, A. Valencia, A. Zorzano, and M. Palacin Heteromeric amino acid transporters: biochemistry, genetics, and physiology Am J Physiol Renal Physiol, December 1, 2001; 281(6): F995 - F1018. [Abstract] [Full Text] [PDF]

				C. A. Wagner, F. Lang, and S. Broer Function and structure of heterodimeric amino acid transporters Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1077 - C1093. [Abstract] [Full Text] [PDF]

				J. Y. Cho, D. A. Fox, V. Horejsi, K. Sagawa, K. M. Skubitz, D. R. Katz, and B. Chain The functional interactions between CD98, {beta}1-integrins, and CD147 in the induction of U937 homotypic aggregation Blood, July 15, 2001; 98(2): 374 - 382. [Abstract] [Full Text] [PDF]

				P. T.-Y. Ayuk, C. P. Sibley, P. Donnai, S. D'Souza, and J. D. Glazier Development and polarization of cationic amino acid transporters and regulators in the human placenta Am J Physiol Cell Physiol, June 1, 2000; 278(6): C1162 - C1171. [Abstract] [Full Text] [PDF]

				R. Zent, C. A. Fenczik, D. A. Calderwood, S. Liu, M. Dellos, and M. H. Ginsberg Class- and Splice Variant-specific Association of CD98 with Integrin beta Cytoplasmic Domains J. Biol. Chem., February 18, 2000; 275(7): 5059 - 5064. [Abstract] [Full Text] [PDF]

				S Daenke and S Booth HTLV-1-induced cell fusion is limited at two distinct steps in the fusion pathway after receptor binding J. Cell Sci., January 1, 2000; 113(1): 37 - 44. [Abstract] [PDF]

				I. C. D. Johnston, V. ter Meulen, J. Schneider-Schaulies, and S. Schneider-Schaulies A Recombinant Measles Vaccine Virus Expressing Wild-Type Glycoproteins: Consequences for Viral Spread and Cell Tropism J. Virol., August 1, 1999; 73(8): 6903 - 6915. [Abstract] [Full Text]

				M. Tsurudome, M. Ito, S.-I. Takebayashi, K. Okumura, M. Nishio, M. Kawano, S. Kusagawa, H. Komada, and Y. Ito Cutting Edge: Primary Structure of the Light Chain of Fusion Regulatory Protein-1/CD98/4F2 Predicts a Protein with Multiple Transmembrane Domains That Is Almost Identical to the Amino Acid Transporter E16 J. Immunol., March 1, 1999; 162(5): 2462 - 2466. [Abstract] [Full Text] [PDF]

				B. A. Mannion, T. V. Kolesnikova, S. H. Lin, S. Wang, N. L. Thompson, and M. E. Hemler The Light Chain of CD98 Is Identified as E16/TA1 Protein J. Biol. Chem., December 11, 1998; 273(50): 33127 - 33129. [Abstract] [Full Text] [PDF]